Michail Doukas

Dr. Michail Doukas is a Researcher at the Department of Pathology, Erasmus MC, Erasmus University Rotterdam. His work focuses on oncological research with a particular emphasis on gastrointestinal cancers, immunological mechanisms in cancer treatment, and translational applications of computational pathology. He has contributed to pivotal clinical trials such as the SANO trial evaluating neoadjuvant chemoradiotherapy for esophageal cancer.

Research interests span tumor biology, stromal-lymphocyte interactions in pancreatic cancer, and the impact of metabolic conditions on chronic liver diseases. His recent studies include groundbreaking work on enteric glia diversity in Hirschsprung disease and the role of metabolic dysfunction-associated steatohepatitis in chronic hepatitis B pathogenesis.

Collaborations involve multidisciplinary teams across Europe, focusing on deep learning applications in histopathology, biomarker discovery, and clinical trial methodologies. His research outputs total 169 publications, emphasizing both basic science and clinical translation.